CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
58-32-2 | 双嘧达莫; 潘生丁; 双嘧哌胺醇; 2,6-双(二羟乙基氨基)-4,8-二哌啶基嘧啶并[5,4-d]嘧啶 | Dypyridamole; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido-[5,4-d]pyrimidin; Dipridacot; Dipyridamol; Persantin | C24H40N8O4 | 详情 | 供应商 | |
135062-02-1 | 瑞格列奈; (S)-2-乙氧基-4-[2-[3-甲基-1-[2-(1-哌啶基)苯基]-丁烷基]-氨基]-2-羰乙基苯甲酸 | Repaglinide; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; Novonorm; Prandin | C27H36N2O4 | 详情 | 供应商 | |
81027-50-1 | 4-[(4-氯苯基)亚氨基]-1-异丙基哌啶; 4-氯-N-[1-(1-甲基乙基)-4-亚哌啶基]苯胺 | 4-(4-(Chlorophenyl)imino)-1-isopropyl piperidine; 4-Chloro-N-(1-(1-methylethyl)-4-piperidylidene)benzenamine | C14H19ClN2 | 详情 | 供应商 | |
755038-02-9 | 4-[[(7R)-8-环戊基-7-乙基-5,6,7,8-四氢-5-甲基-6-氧代-2-喋啶基]氨基]-3-甲氧基-N-(1-甲基-4-哌啶基)苯甲? | BI 2536; BI 2536; BI-2536, BoehringerPLK-1 inhibitor; 4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide; Benzamide, 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-; Boehringer PLK-1 inhibitor; BI-2536(R-) | C28H39N7O3 | 详情 | 供应商 | |
1089283-49-7 | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶 | GSK1904529A; GSK1904529A; GSK1904529A : IGF-IR, IGF-IIR inhibitor; N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide; GSK 4529 | 无 | C44H47F2N9O5S | 详情 | 供应商 |
937174-76-0 | 4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-? | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4; 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol; GSK 690693; (R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMI | C21H27N7O3 | 详情 | 供应商 |